BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32448238)

  • 1. Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Xia RY; Hu XY; Fei YT; Willcox M; Wen LZ; Yu MK; Zhang LS; Dai MY; Fei GH; Thomas M; Francis N; Wilkinson T; Moore M; Liu JP
    BMC Complement Med Ther; 2020 May; 20(1):151. PubMed ID: 32448238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Zhang XW; Xia RY; Gao JQ; Liu JJ; Xu DH; Li X; Hu XY; Willcox M; Moore M; Dai MY; Trill J; Fei YT; Liu JP
    Front Pharmacol; 2022; 13():923395. PubMed ID: 35860018
    [No Abstract]   [Full Text] [Related]  

  • 3. Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial.
    Xia R; Fei Y; Zhang L; Jie Z; Fan X; Dai M; Moore M; Willcox M; Hu X; Francis N; Liang C; Fei G; Liu J
    BMJ Open; 2023 Sep; 13(9):e070864. PubMed ID: 37775286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
    Ren H; Jiang Y; Wang S; Wang Y; Wang J
    Medicine (Baltimore); 2021 Jan; 100(1):e24198. PubMed ID: 33429809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The add-on effect of Shufeng Jiedu capsule for treating COVID-19: A systematic review and meta-analysis.
    Sheng X; Chen C; Jiang G; Ji Z; Guo Z; Hu H; Wang H; Zhai J; Zhang D; Zhang J; Guo L
    Front Med (Lausanne); 2022; 9():1020286. PubMed ID: 36325392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial.
    Willcox ML; Hu XY; Oliver T; Thorne K; Boxall C; He G; Simpson C; Brotherwood B; O'Neil A; Waugh R; Tilt E; Trill J; Goward N; Francis N; Thomas M; Little P; Wilkinson T; Liu JP; Griffiths G; Moore M
    Front Pharmacol; 2023; 14():1221905. PubMed ID: 37818189
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systematic review and Meta-analysis of efficacy and safety of Shufeng Jiedu Capsules in treatment of influenza].
    Zhou F; Zhao GZ; Li B; Xu XL; Shi YF; Mao YY; Tian JH; Liu QQ
    Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6216-6224. PubMed ID: 38114228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis.
    Zhang YY; Xia RY; Liang SB; Hu XY; Dai MY; Li YL; Zhao LY; Moore M; Fei YT; Liu JP
    Integr Med Res; 2021 Sep; 10(3):100726. PubMed ID: 33996460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial.
    Lu CL; Yang LQ; Jin XY; Friedemann T; Li YF; Liu XH; Chen XY; Zou XY; Zhang BR; Wang FX; Lin YL; Tang YM; Cao ML; Jiang YL; Gao YF; Liu K; Tao ZG; Robinson N; Schröder S; Liu JP; Lu HZ
    Front Pharmacol; 2024; 15():1383831. PubMed ID: 38863976
    [No Abstract]   [Full Text] [Related]  

  • 10. [Overview of systematic reviews of Shufeng Jiedu Capsules].
    Xu GQ; Zhao QL; Wang XY; Zhang D; Fan S; Zhang HQ; Wang MT; Chen MH; Liu M
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):1103-1113. PubMed ID: 35285211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial.
    Hu XY; Oliver T; Willcox M; Simpson C; Thorne K; Trill J; Francis N; Stuart B; Thomas M; Little P; Liu JP; Griffiths G; Moore M
    Pilot Feasibility Stud; 2022 Dec; 8(1):262. PubMed ID: 36536462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Network Meta-analysis of oral Chinese patent medicines in treatment of acute exacerbation of chronic obstructive pulmonary disease].
    Ding MY; Yang SG; Yu NX; Hong YZ; Ye ZC; Yu XQ
    Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3373-3385. PubMed ID: 37382020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease.
    Chen Y; Shergis JL; Wu L; Yu X; Zeng Q; Xu Y; Guo X; Zhang AL; Xue CC; Lin L
    Complement Ther Med; 2016 Dec; 29():94-108. PubMed ID: 27912964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Chinese Herbal Medicine on Acute Exacerbations of COPD: A Randomized, Placebo-Controlled Study.
    Li J; Zhang H; Ruan H; Si Y; Sun Z; Liu H; Feng J; Wang Y; Li L; Bai L; Sun H
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2901-2912. PubMed ID: 33209019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Chinese herbal medicine combined with conventional medicine on acute exacerbation of chronic obstructive pulmonary disease: a systematic review and Meta-analysis.
    Wen G; Xuanlin LI; Hulei Z; Siyuan L; Yang X; Jiansheng LI
    J Tradit Chin Med; 2023 Apr; 43(2):212-220. PubMed ID: 36994509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systematic review of Chuankezhi injection for treating acute exacerbation of chronic obstructive pulmonary disease].
    Chen SQ; Yang XY; Tang XY; Li M; Liu S; Liang J; Zhang XY; Shang HC
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2789-2795. PubMed ID: 29098839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Network Meta-analysis of 3 kinds of Chinese medicine injections in treatment of acute exacerbations of chronic obstructive pulmonary disease].
    Zhu XY; Xie HF; Han H; Gao F
    Zhongguo Zhong Yao Za Zhi; 2019 May; 44(10):2179-2184. PubMed ID: 31355578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Haifeng W; Hailong Z; Jiansheng L; Xueqing Y; Suyun L; Bin L; Yang X; Yunping B
    Complement Ther Med; 2015 Aug; 23(4):603-11. PubMed ID: 26275654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systematically review of modified Sanzi Yangqin Decoction for treating acute exacerbation of chronic obstructive pulmonary disease].
    Zheng WJ; Peng ZJ; Chen SW; Hong Y; Huang HT; Liao HL; Liu XH
    Zhongguo Zhong Yao Za Zhi; 2019 May; 44(10):2171-2178. PubMed ID: 31355577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.